Skip to Main Content

Author Details

Tetsuo Shioi
Beth Israel Deaconess Medical Center.
1983
78
43
PMIDPaper TitleJournal TitlePublished Year
33495398Correction for McMullen et al., "Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy".Mol Cell Biol2021
29943452Cardiac effects of acute administration of a protonophore in a rat model.J Pharm Pharmacol2018
28772047Kyoto Congestive Heart Failure (KCHF) study: rationale and design.ESC Heart Fail2017
28560105The metabolic profile of a rat model of chronic kidney disease.PeerJ2017
26799652Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).Autophagy2016
25194953Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease.Cardiovasc Interv Ther2015
26141987Branched-chain amino acids ameliorate heart failure with cardiac cachexia in rats.Life Sci2015
25828304Relationships between nutritional status and markers of congestion in patients with pulmonary arterial hypertension.Int J Cardiol2015
25594546Measurement of technetium-99m sestamibi signals in rats administered a mitochondrial uncoupler and in a rat model of heart failure.PLoS One2015
25535334Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genes.Mol Cell Biol2015
23352991Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts.J Mol Cell Cardiol2013
23951293Persistent overexpression of phosphoglycerate mutase, a glycolytic enzyme, modifies energy metabolism and reduces stress resistance of heart in mice.PLoS One2013
23180241Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis.Heart Vessels2013
21839528Analysis of liver metabolism in a rat model of heart failure.Int J Cardiol2012
23068289Aging as a substrate of heart failure.J Cardiol2012
22664754Effects of machine-assisted cycling on exercise capacity and endothelial function in elderly patients with heart failure.Circ J2012
22391413Effect of persistent activation of phosphoinositide 3-kinase on heart.Life Sci2012
21206130MicroRNA, emerging role as a biomarker of heart failure.Circ J2011
21964378Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice.J Mol Cell Cardiol2011
21532182Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization.Circ J2011
21467658Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world.Circ J2011
20237330PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.Arterioscler Thromb Vasc Biol2010
20176713Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure.Circ Heart Fail2010
19122165Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function.Am J Physiol Heart Circ Physiol2009
19679877Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.Am J Pathol2009
19822807Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice.Circulation2009
18332105MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance.Mol Cell Biol2008
18267957Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.Cardiovasc Res2008
17202264Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.Proc Natl Acad Sci U S A2007
17908558A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy.Cell Metab2007
17904155Resistin, an adipocytokine, offers protection against acute myocardial infarction.J Mol Cell Cardiol2007
17322642Resveratrol ameliorates experimental autoimmune myocarditis.Circ J2007
16565569Angiotensin II receptor antagonist attenuates expression of aging markers in diabetic mouse heart.Circ J2006
16679696Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure.Intern Med2006
16043946Rapamycin ameliorates experimental autoimmune myocarditis.Int Heart J2005
16298682Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.Free Radic Biol Med2005
14597618The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.J Biol Chem2004
15226426Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.Mol Cell Biol2004
15184287Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.Circulation2004
12535832Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.J Am Coll Cardiol2003
14507992Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.Proc Natl Acad Sci U S A2003
14662266Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice.J Am Coll Cardiol2003
12668503Rapamycin attenuates load-induced cardiac hypertrophy in mice.Circulation2003
11909972Akt/protein kinase B promotes organ growth in transgenic mice.Mol Cell Biol2002
12297047Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.Cell2002
11407747Proinflammatory cytokine inhibitor prolongs the survival of rats with heart failure induced by pressure overload.Jpn Circ J2001
11457872Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein.J Clin Invest2001
10835352The conserved phosphoinositide 3-kinase pathway determines heart size in mice.EMBO J2000
10553920Cytokine gene expression during the development of graft coronary artery disease in mice.Jpn Circ J1999
10406581Apical hypertrophic cardiomyopathy and hepatitis C virus infection.Jpn Circ J1999
  • 1 - 50 of 78

Recommended Authors

the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2009
Number of shared co-authors 0
University of Alabama at Birmingham.
Career Start Year 2008
Number of shared co-authors 0
Renmin Hospital of Wuhan University
Career Start Year 2007
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
Gladstone Institutes San Francisco
Career Start Year 2004
Number of shared co-authors 0
Division of Clinical Laboratory Medicine, Hyogo College of Medicine
Career Start Year 2002
Number of shared co-authors 0
university of california los angeles
Career Start Year 2002
Number of shared co-authors 0
University of California davis
Career Start Year 2001
Number of shared co-authors 0
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 1
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 1999
Number of shared co-authors 0
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 0
National Institutes of Health, and Blood Institute
Career Start Year 1994
Number of shared co-authors 0
University of California los angeles
Career Start Year 1994
Number of shared co-authors 0
University of Washington
Career Start Year 1993
Number of shared co-authors 0
Medical College of Georgia, Augusta University
Career Start Year 1993
Number of shared co-authors 0
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 3
University of Connecticut Health
Career Start Year 1992
Number of shared co-authors 1
University of California at Los Angeles
Career Start Year 1992
Number of shared co-authors 0
University of Alabama at Birmingham, 1670 University Boulevard
Career Start Year 1989
Number of shared co-authors 1
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 0
Charite University Medicine, Berlin Institute of Health (BIH)
Career Start Year 1988
Number of shared co-authors 5
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1986
Number of shared co-authors 0
University of Maryland
Career Start Year 1986
Number of shared co-authors 0
Center for Molecular Medicine, Maine Medical Center Research Institute
Career Start Year 1985
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 1982
Number of shared co-authors 1
Cardiovascular Research Center, Lewis Katz School of Medicine, Temple University
Career Start Year 1979
Number of shared co-authors 0
University Hospital Wurzburg
Career Start Year 1974
Number of shared co-authors 0
National Academy of Medicine.
Career Start Year 1974
Number of shared co-authors 2
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 0
S.N. Bose National Centre for Basic Sciences
Career Start Year 1970
Number of shared co-authors 1

Collaborators

Beth Israel Deaconess Medical Center.
Co-authored papers 20
Baker Heart and Diabetes Institute
Co-authored papers 14
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 7
Novartis Institutes for BioMedical Research, Inc. Cambridge
Co-authored papers 6
Harvard Medical School, Boston Children's Hospital.
Co-authored papers 6
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 5
Co-authored papers 2
Beth Israel Deaconess Medical Center
Co-authored papers 2
Nova Scotia Health Authority
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Duke Clinical Research Institute, Duke University
Co-authored papers 2
Queen's University Belfast
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Oncode Institute
Co-authored papers 1
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Co-authored papers 1
Co-authored papers 1
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers 1
Beth Israel Deaconess Medical Center
Co-authored papers 1
New York State Psychiatric Institute, Research Foundation for Mental Hygiene
Co-authored papers 1
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Pennsylvania
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Institute for Biophysical Chemistry, Goethe-University
Co-authored papers 1